David B. Klein
FounderFounder and CEO at Click Therapeutics
New York, New York, United States
FoundedClick Therapeutics
Find your path to David
117 people in our graph share verified history with David — schools, employers, funds. One of them is your warm intro.
About
David Benshoof Klein is the founder and CEO of Click Therapeutics, Inc., a company that develops and commercializes software as prescription medical treatments; its products include Rejoyn, developed with Otsuka and FDA-authorized for adjunctive treatment of major depressive disorder symptoms, and CT-132, FDA-authorized for the preventive treatment of episodic migraine. Before founding Click, he was Managing Director at Opus Point Partners, which built and financed companies including Cougar Biotechnology, Chelsea Therapeutics, and TG Therapeutics. He holds a bachelor's degree from Brandeis University, has served as guest faculty at Columbia University, NYU Stern School of Business, and Columbia Business School, and is co-founder of the Eli Klein Gallery.
Founder and CEO at Click Therapeutics
Intro paths
In turn, David can intro founders to Click Therapeutics's investors below.
Click Therapeutics's investors · 11
Co-founders at Click Therapeutics
Founder at Click Therapeutics
Intro paths
In turn, David can intro founders to Click Therapeutics's investors below.
Click Therapeutics's investors · 11
Co-founders at Click Therapeutics
Experience
- Click Therapeutics, Inc.Founder & CEOcurrent2012 — presentNew York City Metropolitan Area
- Eli Klein GalleryCo-Founder & Ownercurrent2006 — presentNew York City Metropolitan Area
- PfizerSenior Consultant2012 — 2014New York City Metropolitan Area
- Opus Point PartnersManaging Director2007 — 2012New York City Metropolitan Area
- Voyager BioSciencesFounder & CEO2001 — 2006New York City Metropolitan Area
Skills & more
+10 more
Talent ManagementTalent AcquisitionTalent DevelopmentTalent AssessmentTalent IdentificationMergersAcquiringReverse MergersPublic SpeakingIPOLanguages Cantonese · English · Hebrew · Mandarin · Spanish
From David's professional profile.
Frequently asked questions
- Who is David B. Klein?
- David Benshoof Klein is the founder and CEO of Click Therapeutics, Inc., a company that develops and commercializes software as prescription medical treatments; its products include Rejoyn, developed with Otsuka and FDA-authorized for adjunctive treatment of major depressive disorder symptoms, and CT-132, FDA-authorized for the preventive treatment of episodic migraine. Before founding Click, he was Managing Director at Opus Point Partners, which built and financed companies including Cougar Biotechnology, Chelsea Therapeutics, and TG Therapeutics. He holds a bachelor's degree from Brandeis University, has served as guest faculty at Columbia University, NYU Stern School of Business, and Columbia Business School, and is co-founder of the Eli Klein Gallery.
- Where does David B. Klein work?
- David B. Klein is Founder of Click Therapeutics.
- What companies did David B. Klein found?
- David B. Klein founded Click Therapeutics.
- Where did David B. Klein go to school?
- David B. Klein studied at Brandeis University (BA); Pardes Channa Agricultural School - Israel; California International School - Hong Kong.
Founder mafias
Brandeis University mafia38
Also came through, then founded or led a company.
+ 31 more
Same school
Also attended Brandeis University122
+ 116 more
Shared employers
Also worked at Click Therapeutics, Inc.8
+ 2 more
Also worked at Pfizer288
+ 282 more